Last reviewed · How we verify
NCT04909931
Vitamin D Supplementation on Outcome and Disease Activity.
NA trial testing Vitamin D 2 in Rheumatoid Arthritis, Vitamin D , Disease Activity, DAS28ESR in 60 participants. Completed in 1 December 2022.
15 May 2022
Quick facts
| Lead sponsor | Department of Medical Services Ministry of Public Health of Thailand |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | sequential |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 1 May 2021 |
| Primary completion | 15 May 2022 |
| Estimated completion | 1 December 2022 |
| Sites | 1 location across Thailand |
Drugs / interventions tested
- Vitamin D 2 — full drug profile →
- Placebo
Conditions studied
- Rheumatoid Arthritis, Vitamin D , Disease Activity, DAS28ESR — all drugs for Rheumatoid Arthritis, Vitamin D , Disease Activity, DAS28ESR →
Sponsor
Department of Medical Services Ministry of Public Health of Thailand
Who can join
18 and older, any sex, with Rheumatoid Arthritis, Vitamin D , Disease Activity, DAS28ESR. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To study efficacy of Vitamin D on outcome and disease activity ; DAS28-ESR in Rheumatoid arthritis patients at Rajavithi hospital .
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04909931
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Vitamin D 2
Trials testing the same drug.
- NCT05458024 — Vitamin D to ENhance TraUma REcovery · Phase 2 · completed
- NCT04591847 — Pregnancy Outcome and Vitamin D Level Among Vitamin D Supplementation During Pregnancy · Phase 3 · completed
Other Department of Medical Services Ministry of Public Health of Thailand trials
Trials by the same sponsor.
- NCT06665737 — Outcomes of Early and Late Administration G-CSF for Primary Prophylaxis in Non-Hodgkin's Lymphoma Patients · Phase 4 · not yet recruiting
- NCT06763575 — Efficacy of Surgical Glove-Compression Therapy As a Prevention of Paclitaxel-Induced Peripheral Neuropathy · NA · recruiting
- NCT06860659 — Efficacy of 0.28% Sodium Hyaluronate Eye Drops in Patient With Moderate to Severe Dry Eye · Phase 4 · enrolling by invitation
- NCT06525870 — Efficacy of Topical 85% TCA in the Treatment of LSIL After Low-grade Abnormality of Screening Test: a Randomized Control · Phase 2 · enrolling by invitation
- NCT06436833 — Comparison of Bowel Preparation Using 2 Liter Polyethylene Glycol Regimen Plus Elobixibat Versus 4-Liter Polyethylene Gl · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04909931 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Department of Medical Services Ministry of Public Health of Thailand
- Last refreshed: 7 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04909931.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing